Total Payments
$13,182
2024 Payments
$602.82
Companies
19
Transactions
123
Medicare Patients
22,767
Medicare Billing
$15.5M
Payment Breakdown by Category
Other$7,035 (53.4%)
Food & Beverage$3,212 (24.4%)
Consulting$2,500 (19.0%)
Travel$346.61 (2.6%)
Education$87.92 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,035 | 1 | 53.4% |
| Food and Beverage | $3,212 | 119 | 24.4% |
| Consulting Fee | $2,500 | 1 | 19.0% |
| Travel and Lodging | $346.61 | 1 | 2.6% |
| Education | $87.92 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis, Inc | $7,035 | 1 | $0 (2017) |
| Allergan, Inc. | $3,343 | 15 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $809.86 | 34 | $0 (2024) |
| Genentech USA, Inc. | $706.03 | 36 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $283.60 | 6 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $136.21 | 8 | $0 (2019) |
| Alimera Sciences, Inc. | $126.38 | 6 | $0 (2018) |
| Alcon Laboratories Inc | $125.06 | 1 | $0 (2018) |
| ABBVIE INC. | $121.90 | 5 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $119.32 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $602.82 | 20 | Apellis Pharmaceuticals, Inc. ($241.26) |
| 2023 | $428.09 | 18 | Regeneron Healthcare Solutions, Inc. ($172.50) |
| 2022 | $271.11 | 8 | Regeneron Healthcare Solutions, Inc. ($122.07) |
| 2021 | $199.41 | 10 | Regeneron Healthcare Solutions, Inc. ($86.21) |
| 2020 | $74.26 | 4 | Genentech USA, Inc. ($40.22) |
| 2019 | $399.10 | 15 | Kala Pharmaceuticals, Inc. ($119.32) |
| 2018 | $518.05 | 20 | Alcon Laboratories Inc ($125.06) |
| 2017 | $10,689 | 28 | Lumenis, Inc ($7,035) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $115.08 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: EYE CARE | ||||||
| 10/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Ophthalmology | ||||||
| 06/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $93.64 | General |
| Category: Ophthalmology | ||||||
| 06/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/11/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $36.15 | General |
| Category: Ophthalmology | ||||||
| 05/20/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: EYE CARE | ||||||
| 01/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/09/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/30/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: EYE CARE | ||||||
| 10/20/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| 10/18/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 6,053 | 29,711 | $13.5M | $4.0M |
| 2022 | 22 | 5,668 | 20,067 | $13.2M | $3.8M |
| 2021 | 19 | 5,544 | 19,522 | $12.9M | $3.9M |
| 2020 | 16 | 5,502 | 18,847 | $12.6M | $3.8M |
Total Patients
22,767
Total Services
88,147
Medicare Billing
$15.5M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 347 | 2,812 | $5.6M | $1.9M | 34.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 129 | 1,714 | $1.4M | $371,730 | 27.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 41 | 11,580 | $810,600 | $333,021 | 41.1% |
| J3490 | Unclassified drugs | Office | 2023 | 84 | 149 | $620,000 | $285,643 | 46.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 123 | 1,288 | $1.0M | $240,666 | 23.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 553 | 2,145 | $1.6M | $239,659 | 15.3% |
| 92134 | Imaging of retina | Office | 2023 | 1,361 | 3,751 | $637,670 | $135,526 | 21.3% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 52 | 1,035 | $306,000 | $122,768 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 740 | 1,168 | $350,400 | $89,454 | 25.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 575 | 1,073 | $268,250 | $87,136 | 32.5% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 33 | 260 | $208,000 | $45,131 | 21.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 334 | 390 | $175,500 | $42,999 | 24.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 672 | 997 | $89,730 | $20,917 | 23.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 140 | 140 | $63,000 | $18,237 | 28.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 117 | 119 | $35,700 | $14,806 | 41.5% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 24 | 25 | $162,500 | $13,954 | 8.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $26,550 | $8,543 | 32.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 443 | 611 | $51,935 | $8,226 | 15.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 40 | 125 | $12,500 | $5,756 | 46.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 23 | 89 | $44,500 | $5,037 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 29 | $10,150 | $3,368 | 33.2% |
| 92250 | Photography of the retina | Office | 2023 | 82 | 95 | $16,625 | $3,352 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $8,700 | $2,902 | 33.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 24 | 28 | $5,460 | $1,224 | 22.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 320 | 2,606 | $5.2M | $1.9M | 35.8% |
About Dr. David Rhee, MD
Dr. David Rhee, MD is a Ophthalmology healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417177569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Rhee, MD has received a total of $13,182 in payments from pharmaceutical and medical device companies, with $602.82 received in 2024. These payments were reported across 123 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,035).
As a Medicare-enrolled provider, Rhee has provided services to 22,767 Medicare beneficiaries, totaling 88,147 services with total Medicare billing of $15.5M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Great Neck, NY
- Active Since 04/30/2007
- Last Updated 10/08/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1417177569
Products in Payments
- OZURDEX (Drug) $3,465
- Lucentis (Biological) $447.24
- EYLEA (Biological) $400.41
- Vabysmo (Drug) $246.78
- Syfovre (Drug) $241.26
- EYLEA HD (Biological) $210.04
- EYLEA AFLIBERCEPT INJECTION (Biological) $199.41
- ACTHAR (Biological) $136.21
- ACTIVEFOCUS (Device) $125.06
- INVELTYS (Drug) $119.32
- AcrySof IQ PanOptix UV IOL (Device) $106.49
- Iluvien (Drug) $91.06
- Tecnis Multifocal Family of 1-piece IOLS (Device) $79.60
- Cimerli (Biological) $72.10
- LOTEMAX GEL (Drug) $24.99
- VABYSMO (Drug) $24.69
- BEOVU (Drug) $22.73
- VISUDYNE (Drug) $22.35
- DARAPRIM (Drug) $19.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Great Neck
Dr. Jonathan Jonisch, Md, MD
Ophthalmology — Payments: $622,818
Ophthalmology $622,818
Philip Ferrone, Md, MD
Ophthalmology — Payments: $144,807
Ophthalmology $144,807
Kenneth Rosenthal, Md, MD
Ophthalmology — Payments: $72,719
Ophthalmology $72,719
George Tung, Md, MD
Ophthalmology — Payments: $7,576
Ophthalmology $7,576
Juan Romero, Md, MD
Ophthalmology — Payments: $6,910
Ophthalmology $6,910
Richard Russell, M.d, M.D
Ophthalmology — Payments: $5,822
Ophthalmology $5,822